NeuroPace, Inc. (NASDAQ:NPCE) Receives $15.50 Consensus Target Price from Analysts
NeuroPace, Inc. (NASDAQ:NPCE – Get Free Report) has earned an average rating of “Moderate Buy” from the six research firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year price objective among […]
NeuroPace, Inc. (NASDAQ:NPCE – Get Free Report) has earned an average rating of “Moderate Buy” from the six research firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year price objective among […]
